Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS

NCT04257500 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG: Etonogestrel/ethinyl estradiol vaginal ring

Sponsor

Andrea Roe, MD, MPH